|This article does not cite any sources. (December 2009) (Learn how and when to remove this template message)|
|AHFS/Drugs.com||Micromedex Detailed Consumer Information|
|Biological half-life||20 hours|
|Chemical and physical data|
|Molar mass||307.427 g/mol|
|3D model (Jmol)||Interactive image|
|(what is this?)|
Levobetaxolol is a drug used to lower the pressure in the eye in treating conditions such as glaucoma. It is typically marketed as a 0.5% ophthalmic solution of levobetaxolol hydrochloride under the trade name Betaxon. Levobetaxolol is a beta-adrenergic receptor inhibitor (beta blocker).
Levobetaxolol inhibits the beta-1-adrenergic receptor. When applied topically, it reduces intra-ocular pressure (IOP) by 16-23% depending on time of day and the individual. It is indicated for IOP reduction in patients with open-angle glaucoma or ocular hypertension. Levobetaxolol has fewer cardiovascular side effects than other beta blockers.